2. Academic Validation
  3. In situ formed chemo-immunotherapeutic hydrogel for suppression of postoperative glioma recurrence and intraoperative hemostasis

In situ formed chemo-immunotherapeutic hydrogel for suppression of postoperative glioma recurrence and intraoperative hemostasis

  • J Control Release. 2025 Aug 25:387:114168. doi: 10.1016/j.jconrel.2025.114168.
Jiahao Meng 1,  Muchao Chen 2,  Feng Gu 3,  Yu Miao 2,  Zhaoxin Ji 2,  Xinying Lv 2,  Xinyu Tao 3,  Jiaxuan Li 3,  Zhichao Tian 3,  Menghan Wang 3,  Juyi Zhang 3,  Haiying Li 3,  Wanchun You 4,  Zhong Wang 5,  Qian Chen 6
Affiliations

Affiliations

  • 1 Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China; Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University, Suzhou, Jiangsu 215123, China.
  • 2 Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University, Suzhou, Jiangsu 215123, China.
  • 3 Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China.
  • 4 Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China. Electronic address: wcyou@suda.edu.cn.
  • 5 Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China. Electronic address: wangzhong761@163.com.
  • 6 Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University, Suzhou, Jiangsu 215123, China. Electronic address: chenqian@suda.edu.cn.
PMID: 40865879 DOI: 10.1016/j.jconrel.2025.114168
Abstract

Glioma recurrence and intraoperative bleeding present significant challenges in the treatment of glioma. Gliomas are highly invasive and prone to rapid recurrence, while achieving effective hemostasis during neurosurgery remains critical for patient safety and successful outcomes. Here, we present an innovative in-situ formed fibrin gel-based drug delivery system (PX-478 + αPD-1@Gel), co-loaded with PX-478, a selective hypoxia-inducible factor 1α (HIF-1α) inhibitor, and anti-programmed cell death receptor 1 (αPD-1), for controlled and sequential drug release. PX-478 primarily induces Apoptosis, arrests the cell cycle, and inhibits the expression of HIF-1α and programmed cell death ligand 1 (PD-L1), thereby alleviating the immunosuppressive tumor microenvironment. This modulation enhances immune T cell infiltration and restores their capacity to eliminate glioma cells. The subsequent release of αPD-1 further amplifies the immune response. This dual intervention significantly suppresses glioma recurrence and prolongs the median survival time in an orthotopic postoperative glioma mouse model. Furthermore, the fibrin gel exhibits rapid coagulation and effective hemostasis, reducing intraoperative bleeding and shortening hemostasis time. This dual-functional system, combining localized chemo-immunotherapy with hemostatic properties, shows substantial promise for improving clinical outcomes in glioma patients.

Keywords

Chemo-immunotherapy; Fibrin gel; Hemostasis; Postoperative glioma recurrence; Tumor microenvironment.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z